Literature DB >> 33557010

Prolactin Rescues Immature B Cells from Apoptosis-Induced BCR-Aggregation through STAT3, Bcl2a1a, Bcl2l2, and Birc5 in Lupus-Prone MRL/lpr Mice.

Rocio Flores-Fernández1, Angélica Aponte-López2,3, Mayra C Suárez-Arriaga2,4, Patricia Gorocica-Rosete5, Alberto Pizaña-Venegas6, Luis Chávez-Sanchéz1, Francico Blanco-Favela1, Ezequiel M Fuentes-Pananá2, Adriana K Chávez-Rueda1.   

Abstract

Self-reactive immature B cells are eliminated through apoptosis by tolerance mechanisms, failing to eliminate these cells results in autoimmune diseases. Prolactin is known to rescue immature B cells from B cell receptor engagement-induced apoptosis in lupus-prone mice. The objective of this study was to characterize in vitro prolactin signaling in immature B cells, using sorting, PCR array, RT-PCR, flow cytometry, and chromatin immunoprecipitation. We found that all B cell maturation stages in bone marrow express the prolactin receptor long isoform, in both wild-type and MRL/lpr mice, but its expression increased only in the immature B cells of the latter, particularly at the onset of lupus. In these cells, activation of the prolactin receptor promoted STAT3 phosphorylation and upregulation of the antiapoptotic Bcl2a1a, Bcl2l2, and Birc5 genes. STAT3 binding to the promoter region of these genes was confirmed through chromatin immunoprecipitation. Furthermore, inhibitors of prolactin signaling and STAT3 activation abolished the prolactin rescue of self-engaged MRL/lpr immature B cells. These results support a mechanism in which prolactin participates in the emergence of lupus through the rescue of self-reactive immature B cell clones from central tolerance clonal deletion through the activation of STAT3 and transcriptional regulation of a complex network of genes related to apoptosis resistance.

Entities:  

Keywords:  Bcl2a1a; Birc5; MRL/lpr mice; STAT3; immature B cells; prolactin; prolactin receptor; systemic lupus erythematosus

Year:  2021        PMID: 33557010      PMCID: PMC7913714          DOI: 10.3390/cells10020316

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  58 in total

1.  Effect of hyperprolactinemia on PRL-receptor expression and activation of Stat and Mapk cell signaling in the prostate of long-term sexually-active rats.

Authors:  Luz I Pascual-Mathey; Fausto Rojas-Duran; Gonzalo E Aranda-Abreu; Jorge Manzo; Deissy Herrera-Covarrubias; David A Muñoz-Zavaleta; Luis I Garcia; Ma Elena Hernandez
Journal:  Physiol Behav       Date:  2016-02-09

Review 2.  Prolactin Receptor Isoforms as the Basis of Tissue-Specific Action of Prolactin in the Norm and Pathology.

Authors:  P A Abramicheva; O V Smirnova
Journal:  Biochemistry (Mosc)       Date:  2019-04       Impact factor: 2.487

3.  Intrinsically disordered cytoplasmic domains of two cytokine receptors mediate conserved interactions with membranes.

Authors:  Gitte W Haxholm; Louise F Nikolajsen; Johan G Olsen; Jacob Fredsted; Flemming H Larsen; Vincent Goffin; Stine F Pedersen; Andrew J Brooks; Michael J Waters; Birthe B Kragelund
Journal:  Biochem J       Date:  2015-04-07       Impact factor: 3.857

4.  BCL-W has a fundamental role in B cell survival and lymphomagenesis.

Authors:  Clare M Adams; Annette S Kim; Ramkrishna Mitra; John K Choi; Jerald Z Gong; Christine M Eischen
Journal:  J Clin Invest       Date:  2017-01-17       Impact factor: 14.808

5.  Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3.

Authors:  Emma M Haapaniemi; Meri Kaustio; Hanna L M Rajala; Arjan J van Adrichem; Leena Kainulainen; Virpi Glumoff; Rainer Doffinger; Heikki Kuusanmäki; Tarja Heiskanen-Kosma; Luca Trotta; Samuel Chiang; Petri Kulmala; Samuli Eldfors; Riku Katainen; Sanna Siitonen; Marja-Liisa Karjalainen-Lindsberg; Panu E Kovanen; Timo Otonkoski; Kimmo Porkka; Kaarina Heiskanen; Arno Hänninen; Yenan T Bryceson; Raija Uusitalo-Seppälä; Janna Saarela; Mikko Seppänen; Satu Mustjoki; Juha Kere
Journal:  Blood       Date:  2014-10-27       Impact factor: 22.113

6.  Clinical relevance of circulating anti-ENA and anti-dsDNA secreting cells from SLE patients and their dependence on STAT-3 activation.

Authors:  Raquel de la Varga Martínez; Beatriz Rodríguez-Bayona; Gustavo A Añez; Fermín Medina Varo; José J Pérez Venegas; José A Brieva; Carmen Rodríguez
Journal:  Eur J Immunol       Date:  2017-05-23       Impact factor: 5.532

7.  Effects of siltuximab on the IL-6-induced signaling pathway in ovarian cancer.

Authors:  Yuqi Guo; Jeffrey Nemeth; Colin O'Brien; Michiro Susa; Xianzhe Liu; Zhan Zhang; Edwin Choy; Henry Mankin; Francis Hornicek; Zhenfeng Duan
Journal:  Clin Cancer Res       Date:  2010-08-10       Impact factor: 12.531

8.  Prolactin signaling enhances colon cancer stemness by modulating Notch signaling in a Jak2-STAT3/ERK manner.

Authors:  Naveen K Neradugomma; Dharmalingam Subramaniam; Ossama W Tawfik; Vincent Goffin; T Rajendra Kumar; Roy A Jensen; Shrikant Anant
Journal:  Carcinogenesis       Date:  2013-11-21       Impact factor: 4.944

9.  Function of Treg Cells Decreased in Patients With Systemic Lupus Erythematosus Due To the Effect of Prolactin.

Authors:  María Victoria Legorreta-Haquet; Karina Chávez-Rueda; Luis Chávez-Sánchez; Hernando Cervera-Castillo; Edgar Zenteno-Galindo; Leonor Barile-Fabris; Rubén Burgos-Vargas; Everardo Álvarez-Hernández; Francisco Blanco-Favela
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

Review 10.  STAT3 signaling in ovarian cancer: a potential therapeutic target.

Authors:  Renba Liang; Xishan Chen; Li Chen; Fangzhu Wan; Kaihua Chen; Yongchu Sun; Xiaodong Zhu
Journal:  J Cancer       Date:  2020-01-01       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.